+ Follow HOOVER INSTITUTION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 627751
[Title] => Nagging questions
[Summary] => The “talking points and proposals” advanced by the Loyola School of Theology and the John J Carroll Institute on Church and Social Issues supposedly for the use of the proponents and opponents of the RH bill in formulating an amended version that will serve the best interest of the Filipinos may be useful in the dialogue between CBCP and PNoy.
[DatePublished] => 2010-11-08 00:00:00
[ColumnID] => 133340
[Focus] => 0
[AuthorID] => 1804883
[AuthorName] => Jose C. Sison
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 334877
[Title] => RP urged to venture into biopharming industry
[Summary] => The Philippines has the potential to become a major player in the $20-million biopharming industry which uses genetically transformed crop plants and livestock animals to produce valuable compounds, especially pharmaceuticals, a leading expert said.
[DatePublished] => 2006-05-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1704647
[AuthorName] => Rocel Felix
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
HOOVER INSTITUTION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 627751
[Title] => Nagging questions
[Summary] => The “talking points and proposals” advanced by the Loyola School of Theology and the John J Carroll Institute on Church and Social Issues supposedly for the use of the proponents and opponents of the RH bill in formulating an amended version that will serve the best interest of the Filipinos may be useful in the dialogue between CBCP and PNoy.
[DatePublished] => 2010-11-08 00:00:00
[ColumnID] => 133340
[Focus] => 0
[AuthorID] => 1804883
[AuthorName] => Jose C. Sison
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 334877
[Title] => RP urged to venture into biopharming industry
[Summary] => The Philippines has the potential to become a major player in the $20-million biopharming industry which uses genetically transformed crop plants and livestock animals to produce valuable compounds, especially pharmaceuticals, a leading expert said.
[DatePublished] => 2006-05-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1704647
[AuthorName] => Rocel Felix
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest